Electrochemical, aptamer-based (E-AB) sensors support continuous, real-time measurements of specific molecular targets in complex fluids such as undiluted serum. They achieve these measurements by using redox-reporter-modified, electrode-attached aptamers that undergo target binding-induced conformational changes which, in turn, change electron transfer between the reporter and the sensor surface. Traditionally, E-AB sensors are interrogated via pulse voltammetry to monitor binding-induced changes in transfer kinetics. While these pulse techniques are sensitive to changes in electron transfer, they also respond to progressive changes in the sensor surface driven by biofouling or monolayer desorption and, consequently, present a significant drift. Moreover, we have empirically observed that differential voltage pulsing can accelerate monolayer desorption from the sensor surface, presumably via field-induced actuation of aptamers. Here, in contrast, we demonstrate the potential advantages of employing cyclic voltammetry to measure electron-transfer changes directly. In our approach, the target concentration is reported via changes in the peak-to-peak separation, Δ, of cyclic voltammograms. Because the magnitude of Δ is insensitive to variations in the number of aptamer probes on the electrode, Δ-interrogated E-AB sensors are resistant to drift and show decreased batch-to-batch and day-to-day variability in sensor performance. Moreover, Δ-based measurements can also be performed in a few hundred milliseconds and are, thus, competitive with other subsecond interrogation strategies such as chronoamperometry but with the added benefit of retaining sensor capacitance information that can report on monolayer stability over time.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acssensors.0c02455DOI Listing

Publication Analysis

Top Keywords

e-ab sensors
12
sensor surface
12
electrochemical aptamer-based
8
peak-to-peak separation
8
separation cyclic
8
cyclic voltammetry
8
electron transfer
8
monolayer desorption
8
changes
6
sensor
5

Similar Publications

Article Synopsis
  • * One particular compound showed excellent performance with effective cross-linking, a stable electrochemical potential, and strong durability, making it ideal for sensor applications.
  • * The compound demonstrated consistent current levels in serum, effectively detecting doxorubicin, thus indicating its potential for developing reliable and sensitive sensors in clinical settings.
View Article and Find Full Text PDF

Carrion's disease, caused by infection with the bacterium (), is effectively treated with antibiotics, but reaches fatality rates of ~90% if untreated. Current diagnostic methods are limited, insufficiently sensitive, or require laboratory technology unavailable in endemic areas. Electrochemical aptamer-based (E-AB) biosensors provide a potential solution for this unmet need, as these biosensors are portable, sensitive, and can rapidly report the detection of small molecule targets.

View Article and Find Full Text PDF

Acute myocardial infarction (AMI) is one of the top contributors to global disease mortality. AMI biomarkers, such as cardiac troponin I (cTnI), are often detected with enzyme-linked immunosorbent assay (ELISA) that suffers from several well-known drawbacks such as poor stability and slow and cumbersome operation. Therefore, it is necessary to develop a new analytical technique that can rapidly analyse and detect cTnI for early screening of AMI.

View Article and Find Full Text PDF

Construction of an electrochemical aptamer-based sensors for rapid quantification of the anticancer drug imatinib in blood to improve drug bioavailability at microdoses.

Int J Biol Macromol

December 2024

Ministry of Education Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350116, China; Department of Anesthesiology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China. Electronic address:

Imatinib (Ima), as a commonly used anticancer drug for the clinical treatment of leukemia and gastrointestinal mesenchymal stromal tumour, requires timely monitoring of patients' blood concentration to ensure efficacy while reducing complications and achieving precision medicine due to its narrow therapeutic window (1-5 μM) and the varying sensitivity and resistance of different patients to Ima. However, traditional assays are slow and cumbersome, so improved and innovative platforms for monitoring Ima in the clinic are necessary. In this work, a nanoporous electrochemical aptamer-based (E-AB) sensor was designed for the detection of Ima and imatinib mesylate (Ima-Mes) in blood.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional RT-qPCR for SARS-CoV-2 detection is highly sensitive but slow and labor-intensive, limiting its use in community screenings.
  • A new electrochemical aptamer-based biosensor (E-AB) was developed to target the SARS-CoV-2 nucleocapsid protein, achieving rapid results within 5 minutes.
  • The biosensor demonstrated high specificity and effectiveness in detecting the N protein in artificial saliva, paving the way for quicker and more accessible saliva-based diagnostics.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!